LivaNova PLC

LIVN Healthcare Medical Devices

LivaNova PLC’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 10.7% from fiscal 2024. In the quarter to June 2026, revenue grew 10.8%, EPS grew 296.0%, free cash flow fell 26.7% and total debt fell 31.8%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

77.60 0.90 −1.15%
Market cap
$4.3B
P/E
22.5×
Fwd P/E
26.0×
Dividend yield
—
F-score
4/9
Altman Z
1.74
Beneish M
−3.30
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
23.83 32.26 0.00 0.00

+8 more quarters

P/S ratio
3.07 2.42 2.42 2.12
P/FCF ratio
29.69 21.07 18.94 15.21
P/Operating CF
67.88 228.44 40.73 33.64
P/B ratio
3.41 2.87 2.80 2.47
Price to Tangible BV
13.73 17.28 18.94 21.73
EV/Sales
2.92 2.25 2.23 1.96
EV/EBITDA
15.76 11.73 10.98 9.65
EV/Operating CF
17.24 13.13 12.18 10.57
EV/FCF
28.23 19.54 17.48 14.08
Quick Ratio
1.06 1.01 1.05 1.04
Current Ratio
1.45 1.33 1.36 1.33
Net Debt/EBITDA
(3.07) (4.07) (4.10) (2.82)
Debt/Assets
11.11% 11.44% 14.45% 16.99%
Debt/Equity
0.22 0.24 0.31 0.38
Asset Turnover
0.57 0.56 0.54 0.53
Operating CF/Net income
0.61 0.68 2.67 3.18
Capex/Depreciation
(1.36) (0.70) (1.22) (1.09)
Interest Coverage
6.90 5.00 5.19 4.97
Research and Development Expense of Revenue
13.74% 16.20% 14.44% 13.58%
Selling, General and Administrative Expense of Revenue
40.48% 39.63% 39.72% 38.72%
Intangible Assets out of Total Assets
0.38 0.40 0.39 0.40
Share Based Compensation of Revenue
4.32% 2.28% 2.60% 2.78%
Graham Net Nets
(0.06) (0.08) (0.09) (0.11)
Graham Number
43.26 31.33 0.00 0.00
Earnings Yield
4.20% 3.10% (7.23%) (7.62%)
Free Cash Flow Yield
3.37% 4.75% 5.28% 6.58%
Revenue per Share
7.11 6.62 6.62 6.55
Operating CF per Share
1.21 0.28 1.51 1.56
Capex per Share
(0.57) (0.26) (0.46) (0.42)
Free Cash Flow per Share
0.64 0.02 1.05 1.14
Cash per Share
9.40 9.87 11.65 11.83
Shareholders Equity per Share
24.11 22.15 22.00 21.18
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
24.11 22.15 22.00 21.18
Free Cash Flow
35.04 0.93 57.45 62.18
Working Capital
318.04 251.76 293.54 269.56
Capital Expenditures
(31.55) (14.29) (24.95) (22.88)
Net Current Asset Value
(290.49) (290.79) (304.45) (303.20)
EV/EBIT
22.91 16.77 15.53 13.67
Capex to Sales
0.08 0.04 0.07 0.06
Price to Operating Income
24.10 18.08 16.83 14.76
Other line items
Average Receivables
225.75 215.68 204.57 204.37
Average Payables
95.16 93.39 83.44 83.02
Average Inventory
168.98 159.76 156.13 164.90
Average Assets
2,573.78 2,537.55 2,556.22 2,539.77
Average Common Equity
1,224.08 1,122.81 1,260.12 1,233.64

Fold the line items

Columns are period end dates